Position history for DRIEHAUS CAPITAL MANAGEMENT LLC's holdings in PROTAGONIST THERAPEUTICS INC
DRIEHAUS CAPITAL MANAGEMENT LLC holds 720,928 shares of PTGX (PROTAGONIST THERAPEUTICS INC), worth $76M as of 2026-Q1. The position was decreased (-34.4% shares). PTGX represents 0.6% of DRIEHAUS CAPITAL MANAGEMENT LLC's portfolio.
Current Value
$76M
Current Shares
720,928
Total Value Change
+$56.7M
Total Shares Change
+164,093
Other major holders of PTGX: BNP PARIBAS FINANCIAL MARKETS, UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC, BlackRock, Inc.
Decreased |
| 720,928 |
-34.4% |
| $76M |
| 0.6% |
| $91.30 |
0 |
| 2025-Q4 | Decreased | 1.1M | -3.6% | $96M | 0.7% | $87.26 | 0 |
| 2025-Q3 | Increased | 1.1M | +50.4% | $75.7M | 0.5% | $65.14 | 58 |
| 2025-Q2 | Increased | 757,710 | +222.3% | $41.9M | 0.3% | $55.69 | 56 |
| 2025-Q1 | Decreased | 235,073 | -30.8% | $11.4M | 0.1% | $48.88 | 0 |
| 2024-Q4 | Decreased | 339,698 | -23.7% | $13.1M | 0.1% | $38.51 | 0 |
| 2024-Q3 | Decreased | 445,352 | -20.0% | $20M | 0.2% | $44.56 | 0 |
| 2024-Q2 | Decreased | 556,835 | -0.7% | $19.3M | 0.2% | $34.65 | 0 |